Trials / Conditions / FGFR3 Gene Mutation

FGFR3 Gene Mutation

8 registered clinical trials studyying FGFR3 Gene Mutation — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Inv NCT06995677	Tyra Biosciences, Inc	Phase 2
Recruiting	Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tu NCT06915753	Tyra Biosciences, Inc	Phase 1
Active Not Recruiting	Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors NCT05544552	Tyra Biosciences, Inc	Phase 1 / Phase 2
Active Not Recruiting	A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer NCT04917809	Memorial Sloan Kettering Cancer Center	Phase 2
Terminated	Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib NCT05052372	xCures	—
Unknown	Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations NCT04096417	Academic and Community Cancer Research United	Phase 2
Terminated	BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer NCT02706691	University of Chicago	Phase 2
Completed	Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous C NCT02965378	SWOG Cancer Research Network	Phase 2 / Phase 3